Dr. Ansuman Satpathy's research focuses on developing new genome sequencing technologies to study immune system function and dysfunction directly in cancer patients. His work employs both single-cell and three-dimensional genome sequencing tools to study the epigenetic regulation of tumor-specific T cells.